We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$5.31M
(-1.5%)
Cap. Flow
-$28M
Cap. Flow
% of AUM
-8.22%
Top 10 Holdings %
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$10.1M |
| 2 |
Vale
VALE
|
+$2.39M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.33M |
| 4 |
Coca-Cola
KO
|
+$2.2M |
| 5 |
Wells Fargo
WFC
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$13.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$7.85M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$6.97M |
| 4 |
Logitech
LOGI
|
+$5.93M |
| 5 |
UBS Group
UBS
|
+$5.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.54% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Healthcare | 13.48% |
| 4 | Technology | 13.47% |
| 5 | Financials | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
301
BeOne Medicines Ltd
ONC
$39.2B
| $217K | 0.06% |
840
+80
| +11% | +$22K |
|
|
BKI
302
DELISTED
Black Knight, Inc. Common Stock
BKI
| $215K | 0.06% |
2,431
+1,441
| +146% | +$131K |
|
303
PUT
Alcon
ALC
$32.8B
| $208K | 0.06% |
360
-1,554
| -81% | -$97.2K |
|
304
Zoom
ZM
$27.2B
| $207K | 0.06% |
+614
| New | +$274K |
|
305
Encompass Health
EHC
$12B
| $207K | 0.06% |
3,146
+1,747
| +125% | +$103K |
|
|
AUY
306
DELISTED
Yamana Gold, Inc.
AUY
| $204K | 0.06% |
35,657
-54,833
| -61% | -$308K |
|
307
Starbucks
SBUX
$110B
| $203K | 0.06% |
1,902
+933
| +96% | +$89.1K |
|
308
Invesco MSCI Sustainable Future ETF
ERTH
$127M
| $203K | 0.06% |
+2,700
| New | +$179K |
|
309
Toll Brothers
TOL
$12.4B
| $199K | 0.06% |
4,574
+2,790
| +156% | +$129K |
|
310
United Airlines
UAL
$34.7B
| $198K | 0.06% |
4,579
+395
| +9% | +$16K |
|
311
State Street SPDR S&P Metals & Mining ETF
XME
$4.48B
| $197K | 0.06% |
5,900
| – | – |
|
312
Trip.com Group
TCOM
$24.7B
| $197K | 0.06% |
5,834
+453
| +8% | +$14.8K |
|
313
HCA Healthcare
HCA
$91.8B
| $195K | 0.06% |
1,188
+159
| +15% | +$23.2K |
|
314
TechnipFMC
FTI
$29.4B
| $195K | 0.06% |
27,649
+1,441
| +5% | +$8.47K |
|
315
Procure Space ETF
UFO
$548M
| $191K | 0.06% |
7,500
| – | – |
|
316
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
| $185K | 0.05% |
2,233
-117
| -5% | -$8.83K |
|
317
Rhythm Pharmaceuticals
RYTM
$6.66B
| $184K | 0.05% |
6,174
| – | – |
|
318
American Tower
AMT
$82.8B
| $182K | 0.05% |
810
+603
| +291% | +$140K |
|
319
Xcel Energy
XEL
$45.3B
| $181K | 0.05% |
2,714
+1,237
| +84% | +$86.2K |
|
320
Dominion Energy
D
$56.2B
| $181K | 0.05% |
2,402
+661
| +38% | +$52.5K |
|
321
QuidelOrtho
QDEL
$729M
| $180K | 0.05% |
+1,002
| New | +$223K |
|
322
Kura Oncology
KURA
$1.01B
| $180K | 0.05% |
5,499
-2,085
| -27% | -$73.3K |
|
323
Regenxbio
RGNX
$525M
| $180K | 0.05% |
3,958
+813
| +26% | +$28.4K |
|
324
American Resources Corp
AREC
$220M
| $178K | 0.05% |
+91,364
| New | +$154K |
|
325
Palantir
PLTR
$415B
| $176K | 0.05% |
+7,489
| New | +$134K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2020 Portfolio in Review
As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $28M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.
- Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
- Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
- Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
- Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
- Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
- Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
- Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.
Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.